Advertisement

Mammakarzinom

  • K. W. Brunner
  • G. Martz

Zusammenfassung

Das Mammakarzinom ist in den industrialisierten Ländern die häufigste Krebsform der Frau. Jede 14. – 15. Frau erkrankt an diesem Tumor.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bonadonna G, Valagussa P (1983) Chemotherapy of breast cancer: Current views and results. Int J Radiat Oncol Biol Phys 9: 279Google Scholar
  2. Brennan J (ed) (1977) Breast cancer research report. UICC Technical Series, vol 27. UICC, GenevaGoogle Scholar
  3. Büchner TH, Urbanitz D, van de Lo J (1985) Therapie des Mammakarzinoms. Mit Beiträgen von Brunner KW, Heilmann H-P, Nagel GA, Schmidt-Matthisen H, Schmidt CG, Senn HJ. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  4. Canellos GP, Hellman S, Veronesi V (1982) The management of early breast cancer. N Engl J Med 306: 1430PubMedCrossRefGoogle Scholar
  5. Carter SK (1981) The interpretation of trials: Combined hormonal therapy and chemotherapy in disseminated breast cancer. Breast Cancer Res Treat 1: 42–52CrossRefGoogle Scholar
  6. Cavalli F, Beer M, Martz G et al. (1982) Gleichzeitige oder sequentielle Hormon-Chemotherapie sowie Vergleich verschiedener Polychemotherapien in der Behandlung des metastasierenden Mammakarzinoms. Schweiz Med Wochenschr 112: 774–783PubMedGoogle Scholar
  7. Donegan WL (1983) Cancer and pregnancy. CA J Clin 33: 194CrossRefGoogle Scholar
  8. Everson RB, Lippman ME, Thompson EB et al. (1980) Clinical correlations of steroid receptors in male breast cancer. Cancer Res 40: 991PubMedGoogle Scholar
  9. Hellman S, Harris JR, Canellos GP, Fisher B (1982) Cancer of the breast. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer principles and practice of oncology. Lippincott, Philadelphia Toronto, pp 914–970Google Scholar
  10. Henderson C, Canellos BP (1980) Cancer of the breast. N Engl J Med 302: 17PubMedCrossRefGoogle Scholar
  11. Kantarjian H, Yap H, Hortobagyi G et al. (1983) Hormonal therapy for metastatic male breast cancer. Arch Intern Med 143: 237PubMedCrossRefGoogle Scholar
  12. Kelsey JL, Hildreth NG (1983) Causative factors in breast cancer. In: Margolese R (ed) Breast cancer. Churchill Livingstone, New York Edinburgh London Melbourne, pp 23–56Google Scholar
  13. Seibert K, Lippman M (1982) Hormone receptors in breast cancer. Clin Oncol 1: 735–794Google Scholar
  14. Valagussa P, DiFronzo G, Bignami P et al. (1981) Prognostic importance of estrogen receptors to select node negative patients for adjuvant chemotherapy. In: Salmon SE, Jones SE (eds) Adjuvant chemotherapy for cancer, vol in. Grune & Stratton, New York pp 329–339Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • K. W. Brunner
  • G. Martz

There are no affiliations available

Personalised recommendations